105 related articles for article (PubMed ID: 27521604)
21. STAT3 protein up-regulates Gα-interacting vesicle-associated protein (GIV)/Girdin expression, and GIV enhances STAT3 activation in a positive feedback loop during wound healing and tumor invasion/metastasis.
Dunkel Y; Ong A; Notani D; Mittal Y; Lam M; Mi X; Ghosh P
J Biol Chem; 2012 Dec; 287(50):41667-83. PubMed ID: 23066027
[TBL] [Abstract][Full Text] [Related]
22. The expression of the von Hippel-Lindau gene product and its impact on invasiveness of human breast cancer cells.
Zia MK; Rmali KA; Watkins G; Mansel RE; Jiang WG
Int J Mol Med; 2007 Oct; 20(4):605-11. PubMed ID: 17786294
[TBL] [Abstract][Full Text] [Related]
23. MRTF-A and STAT3 synergistically promote breast cancer cell migration.
Liao XH; Wang N; Liu LY; Zheng L; Xing WJ; Zhao DW; Sun XG; Hu P; Dong J; Zhang TC
Cell Signal; 2014 Nov; 26(11):2370-80. PubMed ID: 25038455
[TBL] [Abstract][Full Text] [Related]
24. MLLT11/AF1q boosts oncogenic STAT3 activity through Src-PDGFR tyrosine kinase signaling.
Park J; Kim S; Joh J; Remick SC; Miller DM; Yan J; Kanaan Z; Chao JH; Krem MM; Basu SK; Hagiwara S; Kenner L; Moriggl R; Bunting KD; Tse W
Oncotarget; 2016 Jul; 7(28):43960-43973. PubMed ID: 27259262
[TBL] [Abstract][Full Text] [Related]
25. [KLF3 regulates the movement, migration and invasion of breast cancer cells through STAT3].
Lü F; Li C; Yu Y; Liang D; Kong SX; Li ZM; Qin JB; You W
Zhonghua Yi Xue Za Zhi; 2019 Oct; 99(38):3014-3018. PubMed ID: 31607035
[No Abstract] [Full Text] [Related]
26. miR-145-dependent targeting of junctional adhesion molecule A and modulation of fascin expression are associated with reduced breast cancer cell motility and invasiveness.
Götte M; Mohr C; Koo CY; Stock C; Vaske AK; Viola M; Ibrahim SA; Peddibhotla S; Teng YH; Low JY; Ebnet K; Kiesel L; Yip GW
Oncogene; 2010 Dec; 29(50):6569-80. PubMed ID: 20818426
[TBL] [Abstract][Full Text] [Related]
27. Fas Signaling Promotes Gastric Cancer Metastasis through STAT3-Dependent Upregulation of Fascin.
Yang Y; Zhao Q; Cai Z; Cheng G; Chen M; Wang J; Zhong H
PLoS One; 2015; 10(5):e0125132. PubMed ID: 25992623
[TBL] [Abstract][Full Text] [Related]
28. STAT3 cooperates with Twist to mediate epithelial-mesenchymal transition in human hepatocellular carcinoma cells.
Zhang C; Guo F; Xu G; Ma J; Shao F
Oncol Rep; 2015 Apr; 33(4):1872-82. PubMed ID: 25653024
[TBL] [Abstract][Full Text] [Related]
29. Obatoclax analog SC-2001 inhibits STAT3 phosphorylation through enhancing SHP-1 expression and induces apoptosis in human breast cancer cells.
Liu CY; Su JC; Ni MH; Tseng LM; Chu PY; Wang DS; Tai WT; Kao YP; Hung MH; Shiau CW; Chen KF
Breast Cancer Res Treat; 2014 Jul; 146(1):71-84. PubMed ID: 24903225
[TBL] [Abstract][Full Text] [Related]
30. Fucosyltransferase 8 regulation and breast cancer suppression by transcription factor activator protein 2γ.
Ma M; Guo D; Tan Z; Du J; Guan F; Li X
Cancer Sci; 2021 Aug; 112(8):3190-3204. PubMed ID: 34036684
[TBL] [Abstract][Full Text] [Related]
31. FOXF2 deficiency promotes epithelial-mesenchymal transition and metastasis of basal-like breast cancer.
Wang QS; Kong PZ; Li XQ; Yang F; Feng YM
Breast Cancer Res; 2015 Feb; 17(1):30. PubMed ID: 25848863
[TBL] [Abstract][Full Text] [Related]
32. RING1 and YY1 binding protein suppresses breast cancer growth and metastasis.
Zhou H; Li J; Zhang Z; Ye R; Shao N; Cheang T; Wang S
Int J Oncol; 2016 Dec; 49(6):2442-2452. PubMed ID: 27748911
[TBL] [Abstract][Full Text] [Related]
33. The Wdr1-LIMK-Cofilin Axis Controls B Cell Antigen Receptor-Induced Actin Remodeling and Signaling at the Immune Synapse.
Bolger-Munro M; Choi K; Cheung F; Liu YT; Dang-Lawson M; Deretic N; Keane C; Gold MR
Front Cell Dev Biol; 2021; 9():649433. PubMed ID: 33928084
[TBL] [Abstract][Full Text] [Related]
34. Metastasis suppressor 1 (MTSS1) demonstrates prognostic value and anti-metastatic properties in breast cancer.
Parr C; Jiang WG
Eur J Cancer; 2009 Jun; 45(9):1673-83. PubMed ID: 19328678
[TBL] [Abstract][Full Text] [Related]
35. Cyclin D1 overexpression and response to bortezomib treatment in a breast cancer model.
Ishii Y; Pirkmaier A; Alvarez JV; Frank DA; Keselman I; Logothetis D; Mandeli J; O'Connell MJ; Waxman S; Germain D
J Natl Cancer Inst; 2006 Sep; 98(17):1238-47. PubMed ID: 16954476
[TBL] [Abstract][Full Text] [Related]
36. miR-519d-mediated downregulation of STAT3 suppresses breast cancer progression.
Deng X; Zhao Y; Wang B
Oncol Rep; 2015 Oct; 34(4):2188-94. PubMed ID: 26238950
[TBL] [Abstract][Full Text] [Related]
37. Biologic role of activated leukocyte cell adhesion molecule overexpression in breast cancer cell lines and clinical tumor tissue.
Hein S; Müller V; Köhler N; Wikman H; Krenkel S; Streichert T; Schweizer M; Riethdorf S; Assmann V; Ihnen M; Beck K; Issa R; Jänicke F; Pantel K; Milde-Langosch K
Breast Cancer Res Treat; 2011 Sep; 129(2):347-60. PubMed ID: 20972617
[TBL] [Abstract][Full Text] [Related]
38. Twist is transcriptionally induced by activation of STAT3 and mediates STAT3 oncogenic function.
Cheng GZ; Zhang WZ; Sun M; Wang Q; Coppola D; Mansour M; Xu LM; Costanzo C; Cheng JQ; Wang LH
J Biol Chem; 2008 May; 283(21):14665-73. PubMed ID: 18353781
[TBL] [Abstract][Full Text] [Related]
39. Overexpression of SMARCA5 correlates with cell proliferation and migration in breast cancer.
Jin Q; Mao X; Li B; Guan S; Yao F; Jin F
Tumour Biol; 2015 Mar; 36(3):1895-902. PubMed ID: 25377162
[TBL] [Abstract][Full Text] [Related]
40. Mutations affecting the actin regulator WD repeat-containing protein 1 lead to aberrant lymphoid immunity.
Pfajfer L; Mair NK; Jiménez-Heredia R; Genel F; Gulez N; Ardeniz Ö; Hoeger B; Bal SK; Madritsch C; Kalinichenko A; Chandra Ardy R; Gerçeker B; Rey-Barroso J; Ijspeert H; Tangye SG; Simonitsch-Klupp I; Huppa JB; van der Burg M; Dupré L; Boztug K
J Allergy Clin Immunol; 2018 Nov; 142(5):1589-1604.e11. PubMed ID: 29751004
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
